Fig. 5.

¹⁸F-florbetaben PET detects Alzheimer’s disease with high sensitivity and specificity. PET images (upper row) and PET/MRI overlay (lower row) of two paradigmatic cases: a a patient with Alzheimer’s disease dementia, b a healthy control individual, imaged within a worldwide multicenter trial. While in the healthy control, only unspecific uptake in the white matter was observed, this extended to the outer gray matter in the Alzheimer’s disease dementia patient. Reprinted from ref. [26], Copyright (2011) with permission from Elsevier